John K. Lee: First-in-human phase I/II clinical trial of STEAP1 CAR T cell therapy for mCRPC
John K. Lee posted on X:
“First-in-human phase I/II clinical trial of STEAP1 CAR T cell therapy for mCRPC now open to enrollment!”
Jessica Hawley shared this post adding:
“Very hopeful our STEAP1 CART from Fred Hutchinson Cancer Center makes difference for patients with advanced CRPC!
Read Further.
Source: John K. Lee/X and Jessica Hawley/X
John K. Lee is a physician-scientist and Associate Professor-in-Residence in Hematology/Oncology and Urologic Oncology at the David Geffen School of Medicine at UCLA. He specializes in advanced prostate and bladder cancer and leads a federally funded research laboratory at the UCLA Jonsson Comprehensive Cancer Center, focusing on genotype-phenotype relationships and immune-based treatment strategies.
Jessica Hawley is a board-certified medical oncologist and clinical-translational scientist. She is an Assistant Professor at UW Medicine and Fred Hutch. Her research is centered on developing novel immunotherapies and identifying immunologic biomarkers that predict clinical responses in patients with genitourinary malignancies.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023